Zoetis (ZTS) Stock Forecast & Price Target

$144.15 +0.89 (+0.62%)

Closing price 10/17/2025 03:59 PM Eastern

Extended Trading

$143.50 -0.65 (-0.45%)

As of 10/17/2025 06:53 PM Eastern

Compare

Zoetis - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Hold

Based on 9 Analyst Ratings

Sell
0

Hold
5

Buy
4

Based on 9 Wall Street analysts who have issued ratings for Zoetis in the last 12 months, the stock has a consensus rating of "Hold." Out of the 9 analysts, 5 have given a hold rating, and 4 have given a buy rating for ZTS.

Consensus Price Target

$196.71
36.46% Upside

According to the 9 analysts' twelve-month price targets for Zoetis, the average price target is $196.71. The highest price target for ZTS is $244.00, while the lowest price target for ZTS is $155.00. The average price target represents a forecasted upside of 36.46% from the current price of $144.15.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ZTS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Zoetis and its competitors.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZTS Analyst Ratings Over Time

Type	Current Forecast 10/19/24 to 10/19/25	1 Month Ago 9/19/24 to 9/19/25	3 Months Ago 7/21/24 to 7/21/25	1 Year Ago 10/20/23 to 10/19/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	4 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)	9 Buy rating(s)
Hold	5 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$196.71	$200.88	$204.63	$221.44
Forecasted Upside	36.46% Upside	37.75% Upside	38.90% Upside	14.57% Upside
Consensus Rating	Hold	Moderate Buy	Moderate Buy	Buy

ZTS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ZTS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Zoetis Stock vs. The Competition

Type	Zoetis	Medical Companies	S&P 500
Consensus Rating Score	2.44	2.33	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	36.46% Upside	1,357.67% Upside	13.60% Upside
News Sentiment Rating	Positive News See Recent ZTS News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/8/2025	Weiss Ratings 0 of 5 stars		Reiterated Rating	Hold (C-)
9/9/2025	Argus 4 of 5 stars	Jasper Hellweg Not Rated	Reiterated Rating	Buy	$190.00	+25.61%
8/11/2025	Piper Sandler 2 of 5 stars	David Westenberg Not Rated	Boost Target	Overweight	$210.00 ➝ $215.00	+45.92%
7/17/2025	Leerink Partnrs Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
7/17/2025	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform	$180.00 ➝ $155.00	+2.34%
6/18/2025	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Block Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$165.00 ➝ $160.00	-1.01%
5/7/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrea Alfonso Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$189.00 ➝ $170.00	+11.26%
2/14/2025	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Balaji Prasad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$242.00 ➝ $244.00	+52.72%
2/14/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erin Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$243.00 ➝ $238.00	+49.95%
10/11/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Overweight	$225.00 ➝ $230.00	+20.70%
Get the Latest News and Ratings for ZTS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Zoetis and its competitors with MarketBeat's FREE daily newsletter.
8/12/2024	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	M. Massaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$220.00 ➝ $225.00	+22.75%
5/8/2024	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$230.00 ➝ $225.00	+36.80%
5/6/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$223.00 ➝ $196.00	+17.58%
12/19/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy	$230.00	+16.03%
12/7/2023	BNP Paribas Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Outperform	$237.00	+30.22%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 01:06 PM ET.

Should I Buy Zoetis Stock? ZTS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, October 14, 2025. Please send any questions or comments about these Zoetis pros and cons to contact@marketbeat.com.

Zoetis
Bull Case

Here are some ways that investors could benefit from investing in Zoetis Inc.:

The current stock price is around $141, which may present a buying opportunity for investors looking for growth in the animal health sector.
Zoetis Inc. reported earnings per share of $1.76, exceeding analysts' expectations, indicating strong financial performance and potential for future growth.
The company has a robust net margin of 27.83%, suggesting efficient management and profitability, which can lead to higher returns for investors.
With a return on equity of 56.90%, Zoetis Inc. demonstrates effective use of shareholder funds to generate profits, making it an attractive investment.
Recent institutional investments, including a significant increase in holdings by Apollon Wealth Management LLC, reflect growing confidence in the company's future prospects.

Zoetis
Bear Case

Investors should be bearish about investing in Zoetis Inc. for these reasons:

Despite strong earnings, the stock has seen fluctuations, with a 1-year high of $196.55 and a low of $139.34, indicating potential volatility.
Analysts have mixed ratings, with some downgrading the stock from "buy" to "hold," which may suggest uncertainty about future performance.
The company's PEG ratio of 2.26 indicates that the stock may be overvalued relative to its growth rate, which could deter value-focused investors.
Zoetis Inc. has a debt-to-equity ratio of 1.05, which may raise concerns about financial leverage and the company's ability to manage debt effectively.
Recent market trends show a competitive landscape in the animal health sector, which could impact Zoetis Inc.'s market share and profitability moving forward.

ZTS Forecast - Frequently Asked Questions

: According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Zoetis is $196.71, with a high forecast of $244.00 and a low forecast of $155.00.
: 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zoetis in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ZTS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ZTS, but not buy additional shares or sell existing shares.
: According to analysts, Zoetis's stock has a predicted upside of 36.46% based on their 12-month stock forecasts.
: Zoetis has been rated by research analysts at Argus, Piper Sandler, and Weiss Ratings in the past 90 days.
: Analysts like Zoetis more than other "medical" companies. The consensus rating score for Zoetis is 2.44 while the average consensus rating score for "medical" companies is 2.33. Learn more on how ZTS compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:ZTS) was last updated on 10/19/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zoetis (ZTS) Stock Forecast & Price Target